Neuroaxonal damage in natalizumab-treated MS patients: The role of JCV antibody titres. Dalla Costa G, Leocani L, Pisa M, Croese T, et al. Mult Scler 2024 Jun 14:13524585241260977. doi: 10.1177/13524585241260977.

Read + Share

Amedeo Smart

Independent Medical Education

Dalla Costa G, Leocani L, Pisa M, Croese T, et al. Neuroaxonal damage in natalizumab-treated MS patients: The role of JCV antibody titres. Mult Scler 2024 Jun 14:13524585241260977. doi: 10.1177/13524585241260977.
PMID: 38877721